NASDAQ · UTMD
Healthcare · Medical - Instruments & Supplies
$69.64
Up+$0.10 (+0.14%)
Updated Sep 11, 2026, 7:33 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
UTMD closed at $69.64 after 20 trading sessions, down 3.41% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $70.01 | $70.20 | $69.10 | $69.64 | 30.59K |
| Sep 9, 2026 | $68.71 | $70.20 | $68.71 | $69.72 | 31.8K |
| Sep 8, 2026 | $70.50 | $70.50 | $68.46 | $69.16 | 35.68K |
| Sep 4, 2026 | $70.64 | $71.62 | $70.64 | $71.10 | 46.03K |
| Sep 3, 2026 | $71.69 | $71.95 | $70.40 | $70.71 | 53.86K |
| Sep 2, 2026 | $71.92 | $72.50 | $71.63 | $71.64 | 31.1K |
| Sep 1, 2026 | $70.58 | $72.28 | $70.55 | $71.76 | 14.25K |
| Aug 31, 2026 | $72.37 | $72.60 | $71.00 | $71.13 | 32.62K |
| Aug 28, 2026 | $72.04 | $73.34 | $71.62 | $72.77 | 32.33K |
| Aug 27, 2026 | $70.05 | $72.08 | $70.05 | $71.80 | 30.54K |
| Aug 26, 2026 | $70.95 | $71.125 | $69.8175 | $70.89 | 31.22K |
| Aug 25, 2026 | $71.90 | $71.90 | $70.35 | $70.96 | 13.99K |
| Aug 24, 2026 | $71.54 | $71.93 | $71.31 | $71.62 | 18.15K |
| Aug 21, 2026 | $71.78 | $72.39 | $69.705 | $71.55 | 114.14K |
| Aug 20, 2026 | $72.25 | $73.30 | $71.15 | $71.42 | 49.85K |
| Aug 19, 2026 | $72.4999 | $73.50 | $72.00 | $72.12 | 63.63K |
| Aug 18, 2026 | $70.80 | $72.45 | $70.80 | $72.00 | 46.77K |
| Aug 17, 2026 | $71.07 | $72.46 | $70.02 | $70.21 | 28K |
| Aug 14, 2026 | $71.93 | $72.60 | $70.58 | $71.00 | 23.98K |
| Aug 13, 2026 | $71.6246 | $72.37 | $71.195 | $72.10 | 10.73K |
The latest Smart Investors Daily articles mentioning UTMD.
UTMD research
Company profile and research snapshot.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Jan 29, 2026
Utah Medical Products (NASDAQ:UTMD) reported quarterly earnings of $0.80 per share. This is a 6.42 percent decrease over earnings of $0.86 per share from the same period last year. The company reported $9.044 million in
Yahoo · Jan 25, 2026
Most readers would already be aware that Utah Medical Products' (NASDAQ:UTMD) stock increased significantly by 7.9...
accessnewswire.com · Nov 4, 2025
SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning UTMD.
